The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy
Authors
Keywords
Molecular radiotherapy, Dosimetry, Dose–effect relationship
Journal
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 41, Issue 10, Pages 1976-1988
Publisher
Springer Nature
Online
2014-06-11
DOI
10.1007/s00259-014-2824-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine: predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapies
- (2012) Verena Hartung-Knemeyer et al. ANNALS OF NUCLEAR MEDICINE
- Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail
- (2012) Sauli Savolainen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: A phase 2 study
- (2012) Vincenzo Mazzaferro et al. HEPATOLOGY
- Tumor Dosimetry and Response for 153Sm-Ethylenediamine Tetramethylene Phosphonic Acid Therapy of High-Risk Osteosarcoma
- (2012) S. Senthamizhchelvan et al. JOURNAL OF NUCLEAR MEDICINE
- Dosimetry Based on 99mTc-Macroaggregated Albumin SPECT/CT Accurately Predicts Tumor Response and Survival in Hepatocellular Carcinoma Patients Treated with 90Y-Loaded Glass Microspheres: Preliminary Results
- (2012) E. Garin et al. JOURNAL OF NUCLEAR MEDICINE
- Experimental facts supporting a red marrow uptake due to radiometal transchelation in 90Y-DOTATOC therapy and relationship to the decrease of platelet counts
- (2011) Stephan Walrand et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Peptide receptor radionuclide therapy with 177Lu-DOTATATE: the IEO phase I-II study
- (2011) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Modified-Release Recombinant Human TSH (MRrhTSH) Augments the Effect of131I Therapy in Benign Multinodular Goiter: Results from a Multicenter International, Randomized, Placebo-Controlled Study
- (2011) H. Graf et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Efficacy of DosimetricVersusEmpiric Prescribed Activity of131I for Therapy of Differentiated Thyroid Cancer
- (2011) Joanna Klubo-Gwiezdzinska et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Dosimetric Analysis of 177Lu-cG250 Radioimmunotherapy in Renal Cell Carcinoma Patients: Correlation with Myelotoxicity and Pretherapeutic Absorbed Dose Predictions Based on 111In-cG250 Imaging
- (2011) A. B. Stillebroer et al. JOURNAL OF NUCLEAR MEDICINE
- Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90 Y microsphere brachytherapy in the treatment of hepatic malignancies
- (2011) William A. Dezarn et al. MEDICAL PHYSICS
- Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapy
- (2010) Ludovic Ferrer et al. CANCER
- Bio-effect model applied to 131I radioimmunotherapy of refractory non-Hodgkin’s lymphoma
- (2010) Peter L. Roberson et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EANM Dosimetry Committee guidelines for bone marrow and whole-body dosimetry
- (2010) Cecilia Hindorf et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EANM procedure guidelines for therapy of benign thyroid disease
- (2010) Marcel P. M. Stokkel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Radioiodine therapy dosimetry in benign thyroid disease and differentiated thyroid carcinoma
- (2010) Massimo Salvatori et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy of Nodular Goiter Allows Major Reduction of the Radiation Burden with Retained Efficacy
- (2010) Søren Fast et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- 131I-Tositumomab Radioimmunotherapy: Initial Tumor Dose-Response Results Using 3-Dimensional Dosimetry Including Radiobiologic Modeling
- (2010) Y. K. Dewaraja et al. JOURNAL OF NUCLEAR MEDICINE
- Efficacy and Toxicity Related to Treatment of Hepatocellular Carcinoma with 90Y-SIR Spheres: Radiobiologic Considerations
- (2010) L. Strigari et al. JOURNAL OF NUCLEAR MEDICINE
- Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study
- (2009) J. B. Cwikla et al. ANNALS OF ONCOLOGY
- A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer
- (2009) Glenn D. Flux et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer
- (2009) Frederik Anton Verburg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Early Dose Response to Yttrium-90 Microsphere Treatment of Metastatic Liver Cancer by a Patient-Specific Method Using Single Photon Emission Computed Tomography and Positron Emission Tomography
- (2009) Janice M. Campbell et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Whole-Body Dosimetry for Individualized Treatment Planning of 131I-MIBG Radionuclide Therapy for Neuroblastoma
- (2009) S. E. Buckley et al. JOURNAL OF NUCLEAR MEDICINE
- Maximal safe dose of I-131 after failure of standard fixed dose therapy in patients with differentiated thyroid carcinoma
- (2008) Jong Jin Lee et al. ANNALS OF NUCLEAR MEDICINE
- 90Y Radioembolization for Metastatic Neuroendocrine Liver Tumors
- (2008) Thomas K. Rhee et al. ANNALS OF SURGERY
- Liver disease induced by radioembolization of liver tumors
- (2008) Bruno Sangro et al. CANCER
- Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
- (2008) Lisa Bodei et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- High-Dose Yttrium-90–Ibritumomab Tiuxetan With Tandem Stem-Cell Reinfusion: An Outpatient Preparative Regimen for Autologous Hematopoietic Cell Transplantation
- (2008) Liliana Devizzi et al. JOURNAL OF CLINICAL ONCOLOGY
- MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response--Implications for Radionuclide Therapy
- (2008) B. W. Wessels et al. JOURNAL OF NUCLEAR MEDICINE
- A NTCP approach for estimating the outcome in radioiodine treatment of hyperthyroidism
- (2008) L. Strigari et al. MEDICAL PHYSICS
- A mathematical approach for evaluating the influence of dose heterogeneity on TCP for prostate cancer brachytherapy treatment
- (2008) L Strigari et al. PHYSICS IN MEDICINE AND BIOLOGY
- Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres
- (2008) Patrick Flamen et al. PHYSICS IN MEDICINE AND BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now